VBI Vaccines Overview
- Year Founded
-
1965

- Status
-
Private
- Employees
-
138

- Latest Deal Type
-
Bankr. Admin/Reorg
VBI Vaccines General Information
Description
VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Contact Information
Website
www.vbivaccines.comCorporate Office
- 160 Second Street
- Floor 3
- Cambridge, MA 02142
- United States
Corporate Office
- 160 Second Street
- Floor 3
- Cambridge, MA 02142
- United States
VBI Vaccines Timeline
VBI Vaccines Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Bankruptcy: Admin/Reorg | 02-Aug-2024 | Completed | Bankruptcy: Admin/Reorg | |||
10. 2PO | 15-May-2024 | Completed | Generating Revenue/Not Profitable | |||
9. PIPE | 11-Apr-2024 | Completed | Generating Revenue/Not Profitable | |||
8. 2PO | 07-Jul-2023 | Completed | Profitable | |||
7. PIPE | 10-Jul-2023 | Completed | Profitable | |||
6. 2PO | 17-Dec-2018 | Completed | Profitable | |||
5. PIPE | 06-Dec-2016 | Completed | Profitable | |||
4. PIPE | 21-Jun-2016 | Completed | Profitable | |||
3. Reverse Merger | 09-Jul-2015 | Completed | Profitable | |||
2. Secondary Transaction - Private | 05-Jun-2012 | $700K | Completed | Profitable |
VBI Vaccines Comparisons
Industry
Financing
Details
VBI Vaccines Competitors (64)
One of VBI Vaccines’s 64 competitors is Novartis, a Corporation company based in Basel, Switzerland.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novartis | Corporation | Basel, Switzerland | ||||
OncBioMune | Corporate Backed or Acquired | Baton Rouge, LA | ||||
IO Biotech | Formerly VC-backed | Copenhagen, Denmark | ||||
Quantum Genomics | Corporation | Paris, France | ||||
GSK | Corporation | Middlesex, United Kingdom |
VBI Vaccines Signals
VBI Vaccines Acquisitions (2)
VBI Vaccines’s most recent deal was a Merger/Acquisition with VBI Vaccines (Acquired in 2016) for . The deal was made on 06-May-2016.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
VBI Vaccines (Acquired in 2016) | 06-May-2016 | Merger/Acquisition | Drug Delivery | ||
Levon Resources (acquired 2015) | 09-Jul-2015 | Merger/Acquisition | Precious Metals and Minerals Mining |
VBI Vaccines ESG
Risk Overview
Risk Rating
Updated August, 30, 2022
28.65 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,842
Rank
Percentile

Pharmaceuticals
Industry
of 898
Rank
Percentile

Biotechnology
Subindustry
of 402
Rank
Percentile

VBI Vaccines FAQs
-
When was VBI Vaccines founded?
VBI Vaccines was founded in 1965.
-
Where is VBI Vaccines headquartered?
VBI Vaccines is headquartered in Cambridge, MA.
-
What is the size of VBI Vaccines?
VBI Vaccines has 138 total employees.
-
What industry is VBI Vaccines in?
VBI Vaccines’s primary industry is Drug Discovery.
-
Is VBI Vaccines a private or public company?
VBI Vaccines is a Private company.
-
What is VBI Vaccines’s current revenue?
The current revenue for VBI Vaccines is
. -
How much funding has VBI Vaccines raised over time?
VBI Vaccines has raised $93.2M.
-
Who are VBI Vaccines’s competitors?
Novartis, OncBioMune, IO Biotech, Quantum Genomics, and GSK are some of the 64 competitors of VBI Vaccines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »